Document is current
Any future updates will be listed below
-
Authors
Levine, Emily S.
Custo Greig, Eugenia
Mendonça, Luísa S. M.
Gulati, Shilpa
Despotovic, Ivana N.
Alibhai, A. Yasin
Moult, Eric
Muakkassa, Nora
Quaranta-El Maftouhi, Maddalena
El Maftouhi, Adil
Chakravarthy, Usha
Fujimoto, James G.
Baumal, Caroline R.
Witkin, Andre J.
Duker, Jay S.
Hartnett, M. Elizabeth
Waheed, Nadia K. https://orcid.org/0000-0002-8229-7519
-
Funding
Funding for this research was provided by:
Massachusetts Lions Club
Research to Prevent Blindness
The Capes Foundation (process no 88887.369769/2019-00)
Foundation for the National Institutes of Health (R01EY015130)
Foundation for the National Institutes of Health (R01EY017011)
Foundation for the National Institutes of Health (R01EY011289)
Foundation for the National Institutes of Health (EY014800)
Champalimaud Vision Award
Beckman-Argyros Award in Vision Science
Retina Research Foundation
Yale School of Medicine
- License Information
-
More Information
Article History
Received: 19 June 2020
Accepted: 11 August 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board for Tufts Medical Center, and patient consent was waived to analyze retrospective data.
: Not applicable.
: AEM: Novartis, Optos, Optovue, Eschenbach (personal fees). MQEM: Novartis, Bayer, Allergan (personal fees). JGF: Topcon (grants); Optovue, Carl Zeiss Meditech (patents); Optovue (consultant, personal financial interest). CRB: Carl Zeiss Meditec, Optovue, Genentech, Allergan (speaker fees). JSD: Carl Zeiss Meditec, Optovue (funding), Aldeyra, Allergan, Aura Biosciences, Bausch Health, Beyeonics, Merck, Novartis, Roche (Consulting); Eleven Oncology, Eye-Point Pharma (Director of Entity); Hemera Biosciences (stock/options). NKW: Nidek, Topcon (Speaker fees); Topcon, Roche/Genentech, Regeneron, Apellis, Astellas, Boehringer Ingelheim, Novartis (Consulting); Roche Genentech, Astellas, Boehringer Ingelheim, Novartis, Carl Zeiss Meditech, Topcon, Carl Zeiss Meditec (Advisory role); Gyroscope (Officer of entity). ESL, ECG, LSMM, SG, IND, AYA, EM, NM, UC, AW, MEH: No disclosures.
